Greenleaf Peter
SEC CIK 1363683 · EDGAR
BoughtSold
Most active insiders at PTHS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davis Todd C | Dir | $1000.0K | — |
| 2 | Friedberg Ezra M | Dir | — | $314.3K |
| 3 | Francis Knuettel II | CFO, Treas, Secty | — | $40.3K |
| 4 | Greenleaf Peter | Dir | — | $37.5K |
| 5 | Pauls Matthew | Dir | — | $37.0K |
| 6 | Malamut Richard | Dir | — | $12.3K |
| 7 | Einhorn Andrew J. | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-07-07 17:03 | 2026-07-02 | PTHS | Pelthos Therapeutics Inc. | Greenleaf Peter | Dir | S - Sale | $26.13 | -797 | 23.9K | -3% | -$20.8K |
| MT | 2026-04-06 17:01 | 2026-04-02 | PTHS | Pelthos Therapeutics Inc. | Greenleaf Peter | Dir | S - Sale | $20.92 | -797 | 24.7K | -3% | -$16.7K |
| A | 2026-04-01 17:43 | 2025-07-02 | PTHS | Pelthos Therapeutics Inc. | Greenleaf Peter | Dir | A - Grant | $0.00 | +25.5K | 25.5K | New | $0 |
| D | 2026-03-03 | 2026-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | F - Tax | $14.21 | -100.9K | 1.84M | -5% | -$1.43M |
| D | 2026-03-03 | 2026-02-27 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | A - Grant | $0.00 | +196.4K | 1.94M | +11% | $0 |
| 2026-02-23 | 2026-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | F - Tax | $14.40 | -100.2K | 1.74M | -5% | -$1.44M | |
| 2026-01-05 | 2026-01-02 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | F - Tax | $15.95 | -113.2K | 1.85M | -6% | -$1.81M | |
| 2026-01-05 | 2026-01-02 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | A - Grant | $0.00 | +165.4K | 1.95M | +9% | $0 | |
| DM | 2025-03-04 | 2025-03-03+ | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | S - Sale | $7.96 | -360.5K | 1.79M | -17% | -$2.87M |
| DM | 2025-03-04 | 2025-02-28+ | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | A - Grant | $0.00 | +624.4K | 1.82M | +52% | $0 |
| 2024-03-07 | 2024-03-06 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | S - Sale | $5.60 | -127.0K | 1.52M | -8% | -$711.1K | |
| 2024-02-22 | 2024-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | A - Grant | $0.00 | +661.5K | 1.65M | +67% | $0 | |
| A | 2024-02-22 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | S - Sale | $8.78 | -33.0K | 982.7K | -3% | -$290.2K |
| 2023-03-06 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | S - Sale | $8.94 | -32.8K | 983.0K | -3% | -$292.8K | |
| 2023-03-06 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | A - Grant | — | +667.4K | 1.02M | +192% | — | |
| D | 2022-03-04 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | A - Grant | $0.00 | +28.3K | 42.0K | +206% | $0 |
| D | 2022-03-04 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | CEO, Dir | S - Sale | $12.01 | -9,068 | 33.0K | -22% | -$108.9K |
Purchase Sale Sale after option exercise All abbreviations